Roy Dekel

1.6k total citations
34 papers, 1.2k citations indexed

About

Roy Dekel is a scholar working on Gastroenterology, Surgery and Molecular Biology. According to data from OpenAlex, Roy Dekel has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Gastroenterology, 17 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Roy Dekel's work include Gastroesophageal reflux and treatments (16 papers), Eosinophilic Esophagitis (9 papers) and Gastrointestinal motility and disorders (7 papers). Roy Dekel is often cited by papers focused on Gastroesophageal reflux and treatments (16 papers), Eosinophilic Esophagitis (9 papers) and Gastrointestinal motility and disorders (7 papers). Roy Dekel collaborates with scholars based in Israel, United States and India. Roy Dekel's co-authors include Ronnie Fass, Michael Shapiro, Justin L. Sewell, Ami D. Sperber, Ram Dickman, Zamir Halpern, Nitsan Maharshak, Keren Hod, Colleen Green and Douglas A. Drossman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Oncogene.

In The Last Decade

Roy Dekel

34 papers receiving 1.2k citations

Peers

Countries citing papers authored by Roy Dekel

Since Specialization

Citations

This map shows the geographic impact of Roy Dekel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Dekel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Dekel more than expected).

Fields of papers citing papers by Roy Dekel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Dekel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Dekel. The network helps show where Roy Dekel may publish in the future.

Co-authorship network of co-authors of Roy Dekel

This figure shows the co-authorship network connecting the top 25 collaborators of Roy Dekel. A scholar is included among the top collaborators of Roy Dekel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy Dekel. Roy Dekel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integrase-derived peptides together with CD24-targeted lentiviral particles inhibit the growth of CD24 expressing cancer cells 2021 ·Oncogene ·Shiran Shapira, E. Sh. Finkelshtein, Dina Kazanov, (unknown), (unknown), Abraham Loyter, Daniel Elbirt, (unknown), Eli Brazowski, (unknown), Roy Dekel, Dov Hershkovitz, Arye Blachar, Ido Wolf, Nadir Arber	5
2	Burnout, but not job strain, is associated with irritable bowel syndrome in working adults 2020 ·Journal of Psychosomatic Research ·Keren Hod, Samuel Melamed, Roy Dekel, Nitsan Maharshak, Ami D. Sperber	13
3	Pancreatic cancer in bloom syndrome 2019 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Roy Dekel, Nadir Arber, Shiran Shapira	1
4	The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea‐predominant irritable bowel syndrome 2018 ·Neurogastroenterology & Motility ·Keren Hod, Roy Dekel, Nathaniel A. Cohen, Ami D. Sperber, Yishai Ron, Mona Boaz, Shlomo Berliner, Nitsan Maharshak	44
5	Serum cholinesterase activity is elevated in female diarrhea‐predominant irritable bowel syndrome patients compared to matched controls 2018 ·Neurogastroenterology & Motility ·Keren Hod, Ami D. Sperber, Nitsan Maharshak, (unknown), (unknown), David Zeltser, Ori Rogowski, Shlomo Berliner, Shani Shenhar‐Tsarfaty, Roy Dekel	9
6	The use of psychotropic drugs in irritable bowel syndrome 2013 ·Expert Opinion on Investigational Drugs ·Roy Dekel, Douglas A. Drossman, Ami D. Sperber	54
7	Assessment of high-sensitivity CRP as a marker of micro-inflammation in irritable bowel syndrome 2011 ·Neurogastroenterology & Motility ·Keren Hod, Ram Dickman, Ami D. Sperber, Samuel Melamed, Roy Dekel, Yulia Ron, Zamir Halpern, Shlomo Berliner, Nitsan Maharshak	28
8	Irritable Bowel Syndrome and Co-morbid Gastrointestinal and Extra-gastrointestinal Functional Syndromes 2010 ·Journal of Neurogastroenterology and Motility ·Ami D. Sperber, Roy Dekel	61
9	Relationships Between Sleep Quality and pH Monitoring Findings in Persons with Gastroesophageal Reflux Disease 2007 ·Journal of Clinical Sleep Medicine ·Ram Dickman, Colleen Green, (unknown), Stuart F. Quan, Roy Dekel, (unknown), Ronnie Fass	86
10	Low-Dose Naltreoxone for the Treatment of Irritable Bowel Syndrome: A Pilot Study 2006 ·Digestive Diseases and Sciences ·Revital Kariv, (unknown), (unknown), Roy Dekel, (unknown), Yehuda Ringel, Zamir Halpern	18
11	Assessment of dietary nutrients that influence perception of intra‐oesophageal acid reflux events in patients with gastro‐oesophageal reflux disease 2006 ·Alimentary Pharmacology & Therapeutics ·Michael Shapiro, (unknown), J. Bautista, Roy Dekel, (unknown), (unknown), Ellen Graver, Ronnie Fass	43
12	Esophageal acid exposure at pH ≤ 2 is more common in Barrett’s esophagus patients and is associated with oxidative stress 2006 ·Diseases of the Esophagus ·Katerina Dvorak, Ronnie Fass, Roy Dekel, C. M. Payne, Melissa Chavarria, (unknown), Harris Bernstein, Carol Bernstein, H S Garewal	29
13	Systematic review: proton‐pump inhibitor failure in gastro‐oesophageal reflux disease – where next? 2005 ·Alimentary Pharmacology & Therapeutics ·Ronnie Fass, Michael Shapiro, Roy Dekel, Justin L. Sewell	320
14	Feasibility and tolerability of transnasal/per‐oral placement of the wireless pH capsule vs. traditional 24‐h oesophageal pH monitoring – a randomized trial 2005 ·Alimentary Pharmacology & Therapeutics ·W. M. Wong, J. Bautista, Roy Dekel, Isaac Malagon, (unknown), (unknown), Ram Dickman, Romeo F. Esquivel, Ronnie Fass	83
15	The Role of Proton Pump Inhibitors in Gastro-oesophageal Reflux Disease 2004 ·Drugs ·Roy Dekel, (unknown), Ronnie Fass	50
16	Progression Or Regression of Barrett's Esophagus—Is It All in The Eye of The Beholder? 2003 ·The American Journal of Gastroenterology ·Roy Dekel, (unknown), (unknown), Colleen Green, Richard E. Sampliner, Harinder S. Garewal, Patricia Martinez, Ronnie Fass	29
17	Assessment of oesophageal motor function in patients with dysphagia or chest pain — the Clinical Outcomes Research Initiative experience 2003 ·Alimentary Pharmacology & Therapeutics ·Roy Dekel, Thomas C. Pearson, Christopher S. Wendel, Patricia De Garmo, M. Brian Fennerty, Ronnie Fass	91
18	Evaluation of Symptom Index in Identifying Gastroesophageal Reflux Disease-Related Noncardiac Chest Pain 2003 ·Journal of Clinical Gastroenterology ·Roy Dekel, (unknown), (unknown), Ronnie Fass	42
19	Gliotoxin Ameliorates Development of Fibrosis and Cirrhosis in a Thioacetamide Rat Model 2003 ·Digestive Diseases and Sciences ·Roy Dekel, Isabel Zvibel, Shlomo Brill, (unknown), Zamir Halpern, Ran Oren	47
20	Current perspectives on the diagnosis and treatment of functional esophageal disorders 2003 ·Current Gastroenterology Reports ·Roy Dekel, Ronnie Fass	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact